简介:【摘要】目的 探究3H-6S管理模式在门诊药房中的应用效果。方法 将3H-6S管理模式运用于医院门诊药房质量管理中,分析实施前(2020年1月-6月)和实施后(2020年7月-12月)门诊药房的药品调配差错率、药品调配时间、取药等待时间和患者取药满意度情况的差异。结果 实施3H-6S管理模式后,药品调配差错率显著小于实施前,药品调配时间和取药等待时间显著短与对照组,门诊患者取药满意度则显著高于实施前(P<0.05)。结论 在医院门诊药房实施3H-6S管理模式,可以有效降低门诊药房药品调配差错率,提高门诊药房工作效率和门诊患者取药满意度,值得广泛推广应用。
简介:Lactivicin,anovelinhibitorofbacterialcellwallsynthesis,wasisolatedfromtheculturefil-tratesofmicroorganismYK-258andYK-422.Itexhibitsbiologicalactivitiessimilartothoseoftheβ-lactamantibiotics,althoughitdoesnothaveaβ-lactamringinitsmolecule.Sincethediscoveryoflactivicin,hundredsofitsderivativeshavebeensynthesized.Most
简介:目的:探讨阶段性健康教育在S3~5双开门手术入路行骶前病变手术患者护理中的应用效果。方法:将28例骶前病变患者随机分为2组,其中:观察组18例,对照组10例。对照组采用常规健康教育方法,针对患者现有和潜在的健康问题给予健康指导;观察组实施阶段性健康教育处方,在入院时、术前、术后及出院前,针对患者不同时期的不同需要,采取阶段性、目的明确且持续的健康教育方法。结果:观察组患者对健康教育知晓率明显高于对照组(P〈0.01),满意度高于对照组(P〈0.05)。结论:阶段性健康教育可强化在S3~5双开门手术入路行骶前病变手术患者的遵医行为,建立良好的护患关系,提高患者对健康教育知晓率和满意度,从而促进患者心理和机体功能的早日康复,减少并发症的发生。
简介:Aim:Tostudypercutaneousabsorptionandmetabolismofketoprofenisopropylester(KPE)viaexcisednudemouse'sandmonkey'sskin.Methods:Excisedskinwaspreparedbysurgicalexcisionandenzymedigestion.Sideby-sidediffusioncellswereusedforinvitropermeationstudies.TheconcentrationsofKPEanditsmetaboliteinsampleswereassayedbyHPLC.Results:AllKPEpenetrationthroughwholethicknessskinandstrippedskinwasmetabolizedtoketoprofen(KP).theconcentrationofwhichinthereciiversolutionincreasedlinearlywithtime.Astothenudemouseskin.thesteady-statefluxofKPthroughwholethicknessskinwas2.5timesthatofKPEthroughthewhloethicknessskin,buttheKPandKPEremaininginthewholethicknessskinafterthefinishingofKPEpenetrationwas22.2timesincomperedwiththeKPremaininginthewholethicknessskinafterthefinshingofKPpenetration.TherateofformationofthesteadystateKPfromKPEthroughtdermiswassignificantlylowerthanthatofKPEthroughthewholethicknessskin.Inhemonkeyskin,therateofformationofthesteady-stateKPfromKPEthroughthewholethicknessskinwas0.7timesthatfromKPEthroughstrippedskin.TheKPandKPEremaininginthewholethicknessskinafterthefinishingofKPEpenetrationwas2.0timethatinthestrippedskinafterthefinishingofKPEpenetration.Therateoffornationofthesteady-stateKPfromKPEthroughdermiswaslowerthanthatfromKPEthroughthewholethicknessskinandthestrippedskin.theKPremainingindermisafterthefinsihingofKPEpenetrationwasalsosignificantlylowerthantheKPremaininginthewholethicknessskinandthestrippedskinafterthefinishingofKPEpenetration.Conclusion:KPestersareofbenefittoimporovethelocalactionofKP.andskinesterasemetabolismmainlydevelopsintheepidermis.
简介:3-去氮-NeplanocinA(3-DNPA,2)是具有很强抗病毒抗肿瘤活性的碳环核苷。发展其有效的合成路线,有助于其类似物的合成及进一步的生物活性研究。由2,4.二羟基-3-硝基吡啶起始的3-去氮嘌呤合成,采用-釜反应直接构建咪唑环,避免了中间体10被氧化;同时,碱基合成中副产物11.1的发现和结构确证,提示了一条合成1-去氮嘌呤的新方法。采用微波辅助方法提高了6-氯-3-去氮嘌呤12的肼解及随后的Boc保护制备17的反应产率;而后者提高了偶联反应N9异构体的比例。全部合成工作经十步反应得到3-DNPA,总收率11.2%。
简介:目的探讨乙型肝炎病毒pre—S1Ag、pre—S2Ag、HBV—DNA、HBV—M的相关性及其临床意义。方法HBV—DNA采用荧光定量PCR法;HBV—M及pre—S1Ag、pre—S2Ag采用ELISA法,检测96例HBV—DNA阳性感染者血清中pre-S1Ag、pre—S2Ag、HBV—M,同时以30例HBV—M全阴性的健康体检者血清作为对照,并对结果进行统计学分析。结果96例HBV—DNA阳性患者中HBsAg、HBeAg、HBcAb阳性检出率为64.6%;HBsAg、HBeAb、HBcAb阳性检出率为20.8%;HBsAg、HBcAb阳性栓出率为14.6%;pre—S1Ag在96例HBV—DNA阳性标本中检出率为70.8%;pre—S2Ag检出率为79.2%;均明显高于HBeAg的阳性率64.6%,30例对照中未检测出pre—S1Ag、pre—S2Ag及HBV—DNA。结论HBeAg、HBV—DNA、pre—S1Ag、pre—S2Ag之间具有一定的关联性。pre—S1Ag和pre—S2Ag均较HBeAg敏感。pre—S1Ag与pre—S2Ag的栓出率差异无显著性,ELISA检测HBV—M、pre—S2Ag及pre—S1Ag只是表型指标,只能提供HBV感染的间接证据。而HBV—DNA的检测是HBV感染与否的直接证据。HBV—M、pre—S1Ag、pre—S2Ag、HBV—DNA的检测各自有其独特的临床意义。应用pre—S1Ag、pre—S2Ag、HBV—DNA及HBV—M进行联合检测,对HBV感染的早期诊断,了解HBV复制、转归及监测疗效和预后有重要的意义。
简介:Pyrimidinederivativeshavebeenreportedasneuroprotectiveagentsusefulforthetreatmentofvariousneurodegenerativedisorders.Inthepresentstudy,severalpyrimidineanalogueshavebeenevaluatedasneuroprotectiveagentsinMorriswatermazemodel.Itwasobservedthatpyrimidinederivatives8–17considerablyimprovelearning,memory,andmovementdeficitsinanimalmodels.Biochemicalestimationsofbrainserumoftreatedanimalsrevealedsuppressionofoxidativeandnitrosativestress,acetylcholinesteraseactivity,andotherparameterswhichleadstoneurodegenerationofbrain.Ofallthepyrimidinederivatives,thiomorpholinederivative8andpiperazineethanolderivative17werefoundtobethemostactiveneuroprotectiveagentsandproducedeffectscomparabletostandarddrugrivastigmineintermsofbehavioral,biochemical,andmolecularaspects.